Nu Skin Enterprises, Inc. (NYSE:NUS) will be announcing its earnings results after the market closes on Wednesday, November 1st. Analysts expect the company to announce earnings of $0.95 per share for the quarter. Nu Skin Enterprises has set its Q3 guidance at $0.71-0.76 EPS and its FY17 guidance at $3.20-3.30 EPS.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The company had revenue of $550.10 million during the quarter, compared to the consensus estimate of $548.09 million. During the same quarter last year, the company earned $0.79 earnings per share. Nu Skin Enterprises’s revenue for the quarter was down 8.4% on a year-over-year basis. On average, analysts expect Nu Skin Enterprises to post $3.24 EPS for the current fiscal year and $3.42 EPS for the next fiscal year.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) opened at 63.17 on Wednesday. The firm has a market cap of $3.34 billion, a P/E ratio of 21.13 and a beta of 1.40. The firm has a 50-day moving average of $62.27 and a 200 day moving average of $59.82. Nu Skin Enterprises, Inc. has a 12 month low of $46.35 and a 12 month high of $65.85.

Several research firms recently weighed in on NUS. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Zacks Investment Research lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the stock a “sell” rating in a report on Thursday, August 3rd. Bank of America Corporation boosted their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a report on Monday, July 10th. Finally, BidaskClub lowered Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Nu Skin Enterprises presently has an average rating of “Hold” and an average price target of $62.00.

ILLEGAL ACTIVITY WARNING: “Nu Skin Enterprises, Inc. (NUS) Scheduled to Post Quarterly Earnings on Wednesday” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/25/nu-skin-enterprises-inc-nus-scheduled-to-post-quarterly-earnings-on-wednesday.html.

In other news, General Counsel D Matthew Dorny sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the completion of the transaction, the general counsel now directly owns 52,230 shares in the company, valued at $3,179,762.40. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Ryan S. Napierski sold 6,933 shares of the company’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total value of $443,712.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,040 shares of company stock valued at $1,188,157. Corporate insiders own 5.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.